Vitrolife (Sweden) Market Value
VITR Stock | SEK 212.80 3.00 1.43% |
Symbol | Vitrolife |
Vitrolife 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vitrolife's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vitrolife.
10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Vitrolife on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Vitrolife AB or generate 0.0% return on investment in Vitrolife over 30 days. Vitrolife is related to or competes with SaveLend Group, Viva Wine, Train Alliance, Arctic Blue, Scandic Hotels, Media, and Zenicor Medical. Vitrolife AB , a medical device company, develops, produces, and markets products for assisted reproduction More
Vitrolife Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vitrolife's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vitrolife AB upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 2.47 | |||
Information Ratio | (0.04) | |||
Maximum Drawdown | 16.72 | |||
Value At Risk | (3.62) | |||
Potential Upside | 2.63 |
Vitrolife Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vitrolife's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vitrolife's standard deviation. In reality, there are many statistical measures that can use Vitrolife historical prices to predict the future Vitrolife's volatility.Risk Adjusted Performance | 0.0101 | |||
Jensen Alpha | (0.02) | |||
Total Risk Alpha | (0.32) | |||
Sortino Ratio | (0.04) | |||
Treynor Ratio | 0.0025 |
Vitrolife AB Backtested Returns
Vitrolife AB owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.014, which indicates the firm had a -0.014% return per unit of risk over the last 3 months. Vitrolife AB exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vitrolife's Coefficient Of Variation of 23386.35, semi deviation of 2.39, and Risk Adjusted Performance of 0.0101 to confirm the risk estimate we provide. The entity has a beta of 0.16, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Vitrolife's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vitrolife is expected to be smaller as well. At this point, Vitrolife AB has a negative expected return of -0.0333%. Please make sure to validate Vitrolife's treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to decide if Vitrolife AB performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.43 |
Average predictability
Vitrolife AB has average predictability. Overlapping area represents the amount of predictability between Vitrolife time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vitrolife AB price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Vitrolife price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.43 | |
Spearman Rank Test | 0.22 | |
Residual Average | 0.0 | |
Price Variance | 120.89 |
Vitrolife AB lagged returns against current returns
Autocorrelation, which is Vitrolife stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vitrolife's stock expected returns. We can calculate the autocorrelation of Vitrolife returns to help us make a trade decision. For example, suppose you find that Vitrolife has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Vitrolife regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vitrolife stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vitrolife stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vitrolife stock over time.
Current vs Lagged Prices |
Timeline |
Vitrolife Lagged Returns
When evaluating Vitrolife's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vitrolife stock have on its future price. Vitrolife autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vitrolife autocorrelation shows the relationship between Vitrolife stock current value and its past values and can show if there is a momentum factor associated with investing in Vitrolife AB.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vitrolife Stock Analysis
When running Vitrolife's price analysis, check to measure Vitrolife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitrolife is operating at the current time. Most of Vitrolife's value examination focuses on studying past and present price action to predict the probability of Vitrolife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitrolife's price. Additionally, you may evaluate how the addition of Vitrolife to your portfolios can decrease your overall portfolio volatility.